neostigmine has been researched along with Hyperglycemia in 16 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Excerpt | Relevance | Reference |
---|---|---|
" Microinjection of HgCl2 and neostigmine into the third ventricle under anesthesia caused marked hyperglycemia." | 7.69 | Hypothalamic cholinergic systems in mercuric chloride-induced hyperglycemia. ( Ikarashi, Y; Ishimaru, H; Maruyama, Y; Takahashi, A, 1994) |
"We investigated the effects of intrahypothalamic or hippocampal injection of GABA receptor agonists on hyperglycemia induced by hippocampal neostigmine." | 7.68 | Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats. ( Hiyoshi, Y; Iguchi, A; Maeda, N; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
"We investigated the effect of GABA receptor agonists on the central nervous system (CNS)-mediated hyperglycemia induced by neostigmine or histamine in anesthetized fed rats." | 7.68 | Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia. ( Hiyoshi, Y; Iguchi, A; Li, X; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
" To determine whether brain histamine receptors are involved in cholinergic system transmission with regard to central nervous system (CNS)-mediated glucoregulation, we examined the effects of the H1 receptor antagonist pyrilamine and the H2 receptor antagonist ranitidine on neostigmine-induced hyperglycemia in anesthetized rats." | 7.68 | Role of brain histamine H1- and H2-receptors in neostigmine-induced hyperglycemia in rats. ( Hiyoshi, Y; Iguchi, A; Li, X; Nonogaki, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1992) |
"We previously reported that the injection of neostigmine, an acetylcholine esterase inhibitor, into the dorsal hippocampus produced hepatic venous plasma hyperglycemia associated with an increase of epinephrine and glucagon in anesthetized fed rats." | 7.68 | Mechanism of intrahippocampal neostigmine-induced hyperglycemia in fed rats. ( Goshima, K; Iguchi, A; Ishiguro, T; Miura, H; Nonogaki, K; Sakamoto, N; Tamagawa, T; Uemura, K, 1992) |
"We investigated the relationship between the hyperglycemia induced by the administration of neostigmine into the hippocampus and the hypothalamus." | 7.68 | Hyperglycemia induced by hippocampal administration of neostigmine is suppressed by intrahypothalamic atropine. ( Gotoh, M; Iguchi, A; Ishiguro, T; Kunoh, Y; Miura, H; Nonogaki, K; Sakamoto, N; Tamagawa, T; Uemura, K, 1991) |
"We previously reported that neostigmine injected into the third cerebral ventricle stimulated adrenal secretion of epinephrine, secretion of glucagon from the pancreas, and direct neural innervation of the liver, resulting in hepatic venous plasma hyperglycemia in anesthetized fed rats." | 7.68 | Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats. ( Gotoh, M; Iguchi, A; Matsunaga, H; Miura, H; Sakamoto, N; Satake, T; Tamagawa, T; Uemura, K; Yatomi, A, 1990) |
" Microinjection of HgCl2 and neostigmine into the third ventricle under anesthesia caused marked hyperglycemia." | 3.69 | Hypothalamic cholinergic systems in mercuric chloride-induced hyperglycemia. ( Ikarashi, Y; Ishimaru, H; Maruyama, Y; Takahashi, A, 1994) |
"The contents of hypothalamic neurotransmitters were examined under inducement of hyperglycemia by intraventricular administration of neostigmine, after pretreatment with microwave irradiation." | 3.68 | Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus. ( Ikarashi, Y; Ishimaru, H; Maruyama, Y; Takahashi, A, 1993) |
"We investigated the effects of intrahypothalamic or hippocampal injection of GABA receptor agonists on hyperglycemia induced by hippocampal neostigmine." | 3.68 | Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats. ( Hiyoshi, Y; Iguchi, A; Maeda, N; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
"We investigated the effect of GABA receptor agonists on the central nervous system (CNS)-mediated hyperglycemia induced by neostigmine or histamine in anesthetized fed rats." | 3.68 | Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia. ( Hiyoshi, Y; Iguchi, A; Li, X; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
" To determine whether brain histamine receptors are involved in cholinergic system transmission with regard to central nervous system (CNS)-mediated glucoregulation, we examined the effects of the H1 receptor antagonist pyrilamine and the H2 receptor antagonist ranitidine on neostigmine-induced hyperglycemia in anesthetized rats." | 3.68 | Role of brain histamine H1- and H2-receptors in neostigmine-induced hyperglycemia in rats. ( Hiyoshi, Y; Iguchi, A; Li, X; Nonogaki, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1992) |
"We previously reported that the injection of neostigmine, an acetylcholine esterase inhibitor, into the dorsal hippocampus produced hepatic venous plasma hyperglycemia associated with an increase of epinephrine and glucagon in anesthetized fed rats." | 3.68 | Mechanism of intrahippocampal neostigmine-induced hyperglycemia in fed rats. ( Goshima, K; Iguchi, A; Ishiguro, T; Miura, H; Nonogaki, K; Sakamoto, N; Tamagawa, T; Uemura, K, 1992) |
"We investigated the relationship between the hyperglycemia induced by the administration of neostigmine into the hippocampus and the hypothalamus." | 3.68 | Hyperglycemia induced by hippocampal administration of neostigmine is suppressed by intrahypothalamic atropine. ( Gotoh, M; Iguchi, A; Ishiguro, T; Kunoh, Y; Miura, H; Nonogaki, K; Sakamoto, N; Tamagawa, T; Uemura, K, 1991) |
"We previously reported that neostigmine injected into the third cerebral ventricle stimulated adrenal secretion of epinephrine, secretion of glucagon from the pancreas, and direct neural innervation of the liver, resulting in hepatic venous plasma hyperglycemia in anesthetized fed rats." | 3.68 | Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats. ( Gotoh, M; Iguchi, A; Matsunaga, H; Miura, H; Sakamoto, N; Satake, T; Tamagawa, T; Uemura, K; Yatomi, A, 1990) |
"Neostigmine was injected into the third cerebral ventricle of bilaterally adrenodemedullectomized (ADMX) rats, while somatostatin and insulin were administered intravenously." | 1.28 | Effects of adrenergic blockers on central nervous system-mediated hyperglycemia in fed rats. ( Gotoh, M; Iguchi, A; Kunoh, Y; Mano, T; Miura, H; Nonogaki, K; Sakamoto, N; Tamagawa, T; Uemura, K, 1992) |
"Neostigmine was injected into the third cerebral ventricle and hepatic venous plasma glucose, glucagon, insulin, and epinephrine were measured." | 1.28 | Central nervous system control of glycogenolysis and gluconeogenesis in fed and fasted rat liver. ( Iguchi, A; Kawahara, H; Kunoh, Y; Miura, H; Sakamoto, N; Tamagawa, T; Uemura, K; Yatomi, A, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (18.75) | 18.7374 |
1990's | 11 (68.75) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BRAEUNLICH, H | 1 |
de Andrade, IS | 1 |
Gonzalez, JC | 1 |
Hirata, AE | 1 |
Carneiro, G | 1 |
Amado, D | 1 |
Cavalheiro, EA | 1 |
Dolnikoff, MS | 1 |
Takahashi, A | 2 |
Ishimaru, H | 2 |
Ikarashi, Y | 2 |
Maruyama, Y | 2 |
Ozawa, K | 2 |
Miura, H | 7 |
Tamagawa, T | 8 |
Hiyoshi, Y | 3 |
Nonogaki, K | 6 |
Maeda, N | 1 |
Watanabe, G | 3 |
Sakamoto, N | 9 |
Iguchi, A | 9 |
Brito, NA | 1 |
Brito, MN | 1 |
Kettelhut, IC | 1 |
Migliorini, RH | 1 |
Li, X | 2 |
Gotoh, M | 5 |
Takagi, J | 1 |
Mori, S | 1 |
Yatoh, M | 1 |
Hirooka, Y | 1 |
Yamanouchi, K | 1 |
Smythe, GA | 2 |
Kunoh, Y | 3 |
Uemura, K | 5 |
Mano, T | 1 |
Edwards, SR | 1 |
Ishiguro, T | 2 |
Goshima, K | 1 |
Yatomi, A | 3 |
Matsunaga, H | 2 |
Satake, T | 1 |
Kawahara, H | 1 |
Honmura, A | 1 |
Yanase, M | 1 |
16 other studies available for neostigmine and Hyperglycemia
Article | Year |
---|---|
[THE ALTERATION OF THE HYPERGLYCEMIC EFFECT OF MORPHINE BY OPIATE ANTAGONISTS AND OTHER DRUGS].
Topics: Chemical and Drug Induced Liver Injury; Dimercaprol; Ergotamine; Hepatitis A; Hyperglycemia; Insulin | 1964 |
Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats.
Topics: Animals; Animals, Newborn; Arcuate Nucleus of Hypothalamus; Blood Glucose; Corticotropin-Releasing H | 2006 |
Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Blood Glucose; Cerebral Ventricles; Choline; | 1993 |
Hypothalamic cholinergic systems in mercuric chloride-induced hyperglycemia.
Topics: Animals; Blood Glucose; Extracellular Space; Hyperglycemia; Hypothalamus; Male; Mercuric Chloride; M | 1994 |
Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats.
Topics: Analysis of Variance; Animals; Baclofen; Blood Glucose; Epinephrine; Hepatic Veins; Hippocampus; Hyp | 1993 |
Intra-ventromedial hypothalamic injection of cholinergic agents induces rapid hyperglycemia, hyperlactatemia and gluconeogenesis activation in fed, conscious rats.
Topics: Adrenal Medulla; Animals; Carbachol; Food; Gluconeogenesis; Hyperglycemia; Hypothalamic Area, Latera | 1993 |
Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia.
Topics: Animals; Baclofen; Brain; Central Nervous System; Histamine; Histamine Antagonists; Hyperglycemia; I | 1993 |
Octreotide-induced suppression of the hyperglycemic response to neostigmine or bombesin: relationship to hypothalamic noradrenergic drive.
Topics: Animals; Blood Glucose; Bombesin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Hormo | 2001 |
Effects of adrenergic blockers on central nervous system-mediated hyperglycemia in fed rats.
Topics: Adrenalectomy; Animals; Central Nervous System; Hepatic Veins; Hyperglycemia; Injections, Intraventr | 1992 |
Suppression of central noradrenergic neuronal activity inhibits hyperglycemia.
Topics: Animals; Blood Glucose; Brain; Deoxyglucose; Hyperglycemia; Hypothalamus, Middle; Injections, Intrav | 1992 |
Role of brain histamine H1- and H2-receptors in neostigmine-induced hyperglycemia in rats.
Topics: Animals; Blood Glucose; Brain; Hyperglycemia; Male; Neostigmine; Pyrilamine; Ranitidine; Rats; Rats, | 1992 |
Mechanism of intrahippocampal neostigmine-induced hyperglycemia in fed rats.
Topics: Animals; Epinephrine; Glucagon; Hippocampus; Hyperglycemia; Hypothalamus, Middle; Insulin; Insulin S | 1992 |
Hyperglycemia induced by hippocampal administration of neostigmine is suppressed by intrahypothalamic atropine.
Topics: Animals; Atropine; Blood Glucose; Hexamethonium Compounds; Hippocampus; Hyperglycemia; Hypothalamus; | 1991 |
Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats.
Topics: Adrenergic Fibers; Animals; Atropine; Brain; Hyperglycemia; Injections, Intraventricular; Male; Neos | 1990 |
Central nervous system control of glycogenolysis and gluconeogenesis in fed and fasted rat liver.
Topics: Adrenal Medulla; Animals; Blood Glucose; Cerebral Ventricles; Epinephrine; Fasting; Glucagon; Glucon | 1989 |
Relative contributions of the nervous system and hormones to CNS-mediated hyperglycemia.
Topics: Adrenal Medulla; Animals; Blood Glucose; Cerebral Ventricles; Epinephrine; Glucagon; Hyperglycemia; | 1988 |